SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-17-189241
Filing Date
2017-05-31
Accepted
2017-05-31 16:08:21
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d385151d424b5.htm 424B5 271719
2 GRAPHIC g385151g77z27.jpg GRAPHIC 29986
3 GRAPHIC g385151g77z72.jpg GRAPHIC 24358
4 GRAPHIC g385151g89r58.jpg GRAPHIC 47764
  Complete submission text file 0001193125-17-189241.txt   413874
Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-217573 | Film No.: 17881116
SIC: 2834 Pharmaceutical Preparations